Granulomatosis with polyangiitis features
cANCA +ve
Granulomatosis with polyangiitis mx
- PLEX
Post streptococcal glomerulonephritis ix
Renal biopsy
Post streptococcal glomerulonephritis mx
Liddle’s
AD inheritance High ENaC (mimics hyperaldosteronism) BUT low renin and aldosterone HypoK, metabolic alkalosis HTN
Mx: amiloride
GPA vs anti-GBM differentiation
- raised ESR in GPA, normal in anti-GBM
Bartter syndrome features and mx
NaK2Cl co-transporter mutation (AR) - analogous to loop diuretics
Mx: K / Mg supplementation, NSAIDs, ACEi
Gitelman syndrome features and mx
NaCl transporter mutation DCT - analogous to thiazide use
Mx: K / Mg supplementation, NSAIDs, ACEi
Liddle’s syndrome
AD condition -> high ENaC - mimics hyperaldosteronism
Mx: amiloride
Type 1 (distal) renal tubular acidosis causes
Type 2 (proximal) renal tubular acidosis causes
Type 4 renal tubular acidosis causes
Cast nephropathy
Myeloma with renal involvement as cause
Mx: chemotherapy
- mephalan + corticosteroids
- OR bortezomib + thalidomide + steroids if younger patient
Time-frame for EPO-induced epilepsy
90 days
Isograft
From genetically identical source (identical twin)
Allograft
Genetically different source but same species
Autograft
Same individual is donor and recipient
Heterotopic graft
Graft into different anatomical locations
Orthotopic graft
Graft into same anatomical location
Xenograft
Graft from different species
Fibromuscular dysplasia affecting renal artery
Angio: string of beads appearance
Mx: angioplasty > medical therapy. NB: no role for renal artery re-implantation
Renal artery stenosis
Minimal change disease features features, causes, management, prognosis
Causes
Mx:
1) 80% steroid responsive
2) cyclophosphamide
Prognosis
1/3 one episode
1/3 infrequent relapses
1/3 frequent relapses which stop just before adulthood
Membranous GN features, causes, management, prognosis
Causes
Mx
Prognosis
1/3 spontaneous remission
1/3 remain proteinuric
1/3 ESRF